(Q34590812)

3 August 2017

1 reference

title

Adjuvant and preoperative chemotherapy for gastric cancer (English)

1 reference

preoperative chemotherapy

3 August 2017

1 reference

2

Jaffer A Ajani

1 reference

3 August 2017

James C Yao

1

1 reference

PubMed ID

11937012

3 August 2017

language of work or name

1 reference

1 May 2002

1 reference

3 August 2017

Current Oncology Reports

1 reference

3 August 2017

4

1 reference

3 August 2017

3

1 reference

3 August 2017

222-228

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-002-0019-x

3 August 2017

0 references

cites work

Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-002-0019-X

Neoadjuvant chemotherapy for high-grade advanced gastric cancer

21 January 2018

1 reference

12 December 2020

Positive results of adjuvant mitomycin-C in resected gastric cancer: a randomised trial on 134 patients

1 reference

12 December 2020

Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy

1 reference

12 December 2020

Adjuvant therapy for gastric carcinoma patients in the past 15 years: a review of western and oriental trials

1 reference

12 December 2020

The use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of gastric carcinoma

1 reference

12 December 2020

Randomized trial of adjuvant chemotherapy with mitomycin plus ftorafur versus mitomycin alone in resected locally advanced gastric cancer

1 reference

12 December 2020

Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer.

1 reference

12 December 2020

Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.

1 reference

12 December 2020

Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma

1 reference

12 December 2020

A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer

1 reference

12 December 2020

Estimates of the worldwide incidence of 25 major cancers in 1990.

1 reference

12 December 2020

Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report

1 reference

12 December 2020

Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275).

1 reference

12 December 2020

The effect of adjuvant chemotherapy in gastric carcinoma is dependent on tumor histology: 5-year results of a prospective randomized trial.

1 reference

12 December 2020

The concept of locally advanced gastric cancer. Effect of treatment on outcome. The Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Mitomycin C as an adjuvant in resected gastric cancer

1 reference

12 December 2020

Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma

1 reference

12 December 2020

Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil

1 reference

12 December 2020

Rseults of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence.

1 reference

12 December 2020

USE OF THIO-TEPA AS AN ADJUVANT TO THE SURGICAL MANAGEMENT OF CARCINOMA OF THE STOMACH; V.A. COOPERATIVE SURGICAL ADJUVANT STUDY GROUP

1 reference

12 December 2020

Global cancer statistics

1 reference

12 December 2020

Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma

1 reference

12 December 2020

Prospective randomized trial of combined oncological therapy for gastric carcinoma

1 reference

12 December 2020

Adjuvant intraperitoneal cisplatin therapy in patients with operated gastric carcinoma: results of a randomized trial

1 reference

12 December 2020

Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer

1 reference

12 December 2020

Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study

1 reference

12 December 2020

Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer

1 reference

12 December 2020

A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.

1 reference

12 December 2020

Preoperative chemotherapy for stage III-IV gastric carcinoma: feasibility, response and outcome after complete resection

1 reference

12 December 2020

Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Adjuvant treatments following curative resection for gastric cancer. The Italian Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology

1 reference

12 December 2020

Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study

1 reference

12 December 2020

Neoadjuvant chemotherapy in locally advanced gastric carcinoma--a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum

1 reference

12 December 2020

Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer

1 reference

12 December 2020

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

12 December 2020

Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group

1 reference

12 December 2020

Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: a final report

1 reference

12 December 2020

The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up

1 reference

12 December 2020

Adjuvant chemotherapy in operable gastric cancer. 5 year follow-up of first British Stomach Cancer Group trial

1 reference

12 December 2020

Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer

1 reference

12 December 2020

Cancer statistics, 2001

1 reference

12 December 2020

10.1007/S11912-002-0019-X

Identifiers

DOI

1 reference

PubMed ID

11937012

Dimensions Publication ID

3 August 2017

0 references

1 reference

PubMed ID

11937012